OVERLAND PARK, Kan.--(BUSINESS WIRE)--May 8, 2024--
Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience. Dr. Preskorn is a world-renowned researcher, academic physician, psychiatrist, clinical researcher, neuropsychopharmacologist and medical educator. He has worked with over 140 pharmaceutical, biotech, device and diagnostic companies and has worked on 16 successful new drug applications. His publications include over 500 medical papers, books and book chapters, with over 18,000 citations in medical literature. Further, Dr. Preskorn has served as a consultant to the FDA, EMA and NIH and has lectured in 55 countries and at most medical schools in the U.S. and throughout the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508878546/en/
Sheldon Preskorn, M.D., joins Dr. Vince Clinical Research as its Senior Vice President of Neuroscience. (Photo: Business Wire)
Dr. Preskorn stated: “I have been working in drug development research for 40 years and am pleased to continue my work with DVCR. My lifelong goal has been to advance the treatment of patients suffering from neuropsychiatric disorders and believe this collaboration will greatly advance the ability of our clients to bring breakthrough therapies for patients suffering from these serious medical conditions.”
DVCR CEO and Chief Medical Officer, Brad Vince, D.O., stated: “It is a true honor to work alongside such a well-respected and highly experienced clinical pharmacologist. The addition of Dr. Preskorn to DVCR’s leadership team provides our company and our biopharmaceutical clients access to his significant neurological and psychiatric clinical research expertise.”
About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data ® to their biopharmaceutical clients.
View source version on businesswire.com:https://www.businesswire.com/news/home/20240508878546/en/
CONTACT: Zach Bader
Vice President, Business Development
(913) 333-3000
KEYWORD: KANSAS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL GENERAL HEALTH HEALTH OTHER HEALTH
SOURCE: Dr. Vince Clinical Research
Copyright Business Wire 2024.
PUB: 05/08/2024 09:00 AM/DISC: 05/08/2024 09:00 AM
http://www.businesswire.com/news/home/20240508878546/en
